Clinical Topics & News
Metastatsis to the Bones of the Hand
Unusual Presentations and Complications in Cancer
Fed Pract. 2007 January;24(1):23
Author and Disclosure Information
Jeffrey E. Krygier, MD and Gregory L. DeSilva, MD
Dr. Krygier is an orthopaedic surgery resident at the Detroit Medical Center/Wayne State University training program in Detroit, MI. Dr. DeSilva is an assistant professor in the Wayne State University department of orthopaedic surgery and the chief of orthopaedic services at the John D. Dingell VA Medical Center, both in Detroit.
The rarity with which cancer spreads to the distal skeleton can cause clinicians to miss this diagnosis. These authors describe two cases in which hand metastases were mistaken for infection.
Clinical Topics
-
Pivotal trials in blood cancers don’t mirror patient populations -
Agent Orange Exposure, Transformation From MGUS to Multiple Myeloma, and Outcomes in Veterans -
Many die waiting for `last-chance’ therapy Publish date: August 2, 2022 -
Simultaneous Cases of Carfilzomib-Induced Thrombotic Microangiopathy in 2 Patients With Multiple Myeloma -
Evidence still lacking that vitamins prevent CVD, cancer: USPSTF Publish date: June 24, 2022
Digital Edition
-
AVAHO 2021 Meeting Posters and Abstracts Publish date: September 22, 2021 -
Advances in Hematology and Oncology Publish date: September 3, 2021 -
Advances in Hematology and Oncology Publish date: May 20, 2021 -
August 2020 Advances in Precision Oncology -
Abstracts Presented at the 2020 AVAHO Annual Meeting (Digital Edition)
Multimedia
-
SC daratumumab deemed feasible for every multiple myeloma patient Publish date: July 11, 2019
Conference Coverage
-
Multiprong strategy makes clinical trials less White Publish date: June 23, 2023 -
CBSM phone app eases anxiety, depression in cancer patients Publish date: June 23, 2023 -
CAR T-cell benefit in lenalidomide-refractory myeloma Publish date: June 23, 2023 -
Huge underuse of germline testing for cancer patients Publish date: June 22, 2023 -
Experts debate reducing ASCT for multiple myeloma Publish date: May 3, 2023 -
Many die waiting for `last-chance’ therapy Publish date: August 2, 2022 -
‘Extremely exciting’ study results guide MM treatment options Publish date: June 6, 2022 -
Isatuximab added to RVd boosts response in new myeloma Publish date: December 13, 2021 -
Personalized cancer vaccine shows early promise across tumor types Publish date: April 14, 2021 -
Study found dual-targeted CAR T highly active against relapsed/refractory multiple myeloma Publish date: December 15, 2020
Prognostic factors of bladder cancer
Question 1 of 5